The Gulf Cooperation Council has confirmed that its six member states achieved 100% coverage for essential vaccines in 2024, a milestone that dwarfs the global average of roughly 84% and underscores the region's capacity to deliver universal immunization at a scale few developing nations can match. For the 7.5 million expatriates and citizens living across the UAE and broader GCC, this achievement translates into tangible protection against preventable diseases and represents one of the region's most significant public health accomplishments.
What This Means for UAE Residents
Whether you're a UAE citizen or expatriate, the 100% vaccine coverage milestone offers comprehensive protection for you and your family. Here's what you need to know:
Access and Location: UAE residents can access vaccines through multiple channels, including facilities operated by the Department of Health in Abu Dhabi (DHA) across the emirate, Ministry of Health and Prevention (MOHAP) centers throughout Dubai and other emirates, private health providers, and employer-sponsored health clinics. Most employers, particularly in construction, hospitality, and healthcare sectors, now offer on-site vaccination programs as part of workplace health requirements.
Cost Considerations: Vaccination is free for UAE citizens through all government health facilities. Expatriates typically receive coverage through employer-sponsored health insurance, which mandates routine immunizations as a condition of employment or visa renewal. Those without employer insurance can access vaccines at government clinics at minimal cost, or through private providers covered by individual health insurance plans.
Mandatory Vaccines for School Enrollment: Children—both UAE nationals and expatriates—must receive vaccinations including measles, diphtheria, pertussis, tetanus, polio, hepatitis B, and Hib before school enrollment. These requirements apply across all emirates and are enforced by education authorities.
UAE-Specific Digital Resources: The Al Hosn app, operated by MOHAP, provides residents with digital vaccination records, appointment scheduling, and health information. The platform streamlines access to immunization programs and maintains unified health records across emirates.
Why This Matters
• Full immunization protection: All GCC residents, including those in the UAE, now have access to core vaccines covering at least 13 to 14 antigens, including childhood diseases like measles, polio, and diphtheria.
• Financial commitment: The GCC allocated $842.7M in official development assistance to health research and programs in 2023, representing 4.6% of total international aid flows.
• Regional benchmark: The achievement positions the United Arab Emirates, Saudi Arabia, Qatar, Oman, Kuwait, and Bahrain as reference points for other middle-income countries seeking to close immunization gaps.
• Global health footprint: GCC funding now reaches more than 50 countries, with recent pledges exceeding $1.9B for polio eradication and maternal health initiatives through 2026.
Infrastructure and Procurement Power
Sustained investment in cold-chain logistics, centralized procurement, and digital health systems has allowed GCC health ministries, including the UAE's advanced network, to maintain uninterrupted vaccine delivery even in remote areas. The region's economic stability ensures that vaccine stockouts—a chronic problem in lower-income markets—remain virtually nonexistent.
Most GCC countries negotiate group purchasing agreements with major pharmaceutical manufacturers, securing early access to new formulations and negotiating favorable pricing. This centralized strategy mirrors the approach taken by wealthier European health systems and stands in stark contrast to the fragmented procurement seen in sub-Saharan Africa and parts of South Asia.
Free vaccination for citizens and, in many cases, GCC nationals at public health facilities removes cost as a barrier. Expatriates benefit from employer-sponsored health insurance that typically covers routine immunizations, creating near-universal access across demographic groups.
Understanding Essential Vaccines
The World Health Organization now recommends vaccines including protection against respiratory syncytial virus, tuberculosis, diphtheria, pertussis, tetanus, Haemophilus influenzae type B, hepatitis B, polio, measles, rubella, pneumococcal disease, rotavirus, human papillomavirus (for adolescents), and COVID-19 (for adults). GCC health officials have not published a formal list, but national immunization schedules across all six states now cover at least 13 antigens, with some jurisdictions adding hepatitis A and meningococcal vaccines for high-risk groups.
Oman reported 99.9% coverage for tuberculosis and hepatitis B vaccinations given at birth, and its measles-mumps-rubella and varicella rates reached 99.5% at 12 months. Only 0.01% of Omani children under five remain unvaccinated, a figure that places the sultanate among the world's top performers.
Qatar recorded 97% coverage for diphtheria-tetanus-pertussis and polio in 2023, with pneumococcal vaccination uptake around 95% over the past decade. In Saudi Arabia, measles-mumps-rubella coverage stood at 96% in 2019, and the Ministry of Health has since expanded its schedule to include HPV for adolescents.
Kuwait guarantees free and equitable vaccine access regardless of nationality, a policy that extends to expatriate children enrolled in public clinics. The emirate also offers free HPV vaccination for Kuwaiti nationals aged 9 to 45, though it has not yet incorporated the shot into the mandatory schedule.
Gaps in Seasonal and Adult Immunization
While childhood vaccination rates are exemplary, seasonal influenza uptake tells a different story. Data collected between 2018 and 2024 reveal that median flu vaccination coverage in the general population ranged from 2.8% in Bahrain to 13.8% in Saudi Arabia. Even among healthcare workers—a priority group—rates varied widely: Saudi Arabia achieved 93.2%, while other states lagged below 70%.
Oman stands out for its success with pregnant women, recording 87.4% influenza vaccination in 2024, a rate that exceeds many high-income countries. Yet coverage among Omani children dropped to 4.8% the same year, highlighting the challenge of extending flu campaigns beyond targeted cohorts.
The United Arab Emirates and Kuwait reported less than 1% coverage for childhood flu vaccination in 2024, and Bahrain recorded a similar figure. Public health officials attribute the shortfall to the perception that seasonal flu is a low-severity illness, a misconception that persists despite annual outbreaks in Gulf schools and workplaces.
Adult vaccination for shingles, pneumococcal disease, and RSV remains recommended but not mandatory across the GCC, a gap that may grow more pressing as the region's population ages. Saudi Arabia's Vision 2030 framework includes plans to shift toward prevention and value-based healthcare, which could pave the way for mandatory adult immunization schedules by the end of the decade.
Impact on Residents and Expatriates
For the 7.5 million expatriates living across the GCC, including the approximately 3.5 million living in the UAE alone, the region's vaccine infrastructure offers a level of protection that often exceeds what is available in their home countries. Parents relocating from South Asia, Southeast Asia, or sub-Saharan Africa can enroll children in national immunization programs immediately, closing gaps that may have accumulated due to supply shortages or cost barriers abroad.
Employers in sectors such as construction, hospitality, and domestic work are increasingly required to ensure that expatriate employees receive hepatitis B, measles, and COVID-19 vaccinations as a condition of employment or visa renewal. The United Arab Emirates Ministry of Health and Prevention has mandated workplace vaccination programs in high-risk industries since 2021, a policy that has contributed to the country's high overall coverage and enhanced public health outcomes.
Travelers benefit from the region's advanced meningococcal vaccination infrastructure, particularly in Saudi Arabia, where pilgrims attending Hajj and Umrah must present proof of conjugate meningococcal vaccination. This requirement has effectively eliminated meningococcal outbreaks during the pilgrimage season, a public health success that contrasts sharply with sporadic cases reported in other mass-gathering contexts.
International Development Assistance and Regional Influence
The $842.7M in health-related official development assistance disbursed by GCC states in 2023 represents a notable commitment, but the figure understates the region's broader influence. In December 2025, the Mohamed bin Zayed Foundation for Humanity co-hosted a pledging event in Abu Dhabi that raised $1.9B for polio eradication, with $140M in new funding from the foundation itself. The initiative aims to vaccinate 370M children annually and strengthen health systems against vaccine-preventable diseases in Africa, South Asia, and the Eastern Mediterranean.
The Qatar Fund for Development, which has provided over $1B in health aid to more than 50 countries over the past decade, launched a $4M joint initiative with the World Health Organization in 2024 to enhance primary healthcare and emergency response in low-income countries. In 2025, Qatar pledged an additional $8M to UNICEF to improve child access to health, water, sanitation, and hygiene services.
The United Arab Emirates announced a $550M contribution to the UN's 2026 Global Humanitarian Overview, which seeks to mobilize $33B to assist approximately 135M people across 23 humanitarian response plans. The Emirates' Reaching the Last Mile Fund continues its fight against neglected tropical diseases such as river blindness and lymphatic filariasis in Africa and Yemen, a multi-year effort that complements the Foundation's broader maternal and newborn health programs.
Kuwait Fund for Development contributed $1.5M to UNICEF in December 2024 to sustain primary healthcare services for vulnerable populations in Yemen, aiming to strengthen national health systems and improve outcomes for women, girls, and boys caught in a protracted humanitarian crisis.
UAE's Digital Health Leadership
The United Arab Emirates has emerged as a leader in digital health transformation within the region. The integration of AI-driven diagnostic systems, virtual consultations, and unified health information systems—particularly through MOHAP's comprehensive platform—has streamlined vaccine delivery and health records management. This digital infrastructure ensures that residents and expatriates can easily track vaccination status, schedule appointments, and access immunization information through the Al Hosn app and health provider portals.
Oman has expanded AI-driven diagnostics, with its National Programme for Diabetic Retinopathy Screening processing over 30,000 patients at 92% accuracy, cutting waiting times by more than 80%. Virtual medical consultations have become routine, and the integration of health institutions into digital systems is progressing under Vision 2040.
Bahrain has advanced health innovation by expanding digital health services, developing advanced epidemiological monitoring systems, and implementing a National Genome Project to support personalized medicine and early disease detection. Kuwait is investing $10B in healthcare infrastructure for 2024 and 2025, modernizing health information systems and building the capacity of healthcare professionals across 20 strategic projects.
Saudi Arabia's Vision 2030 anticipates annual savings between SAR 40B and SAR 65B by 2035 due to improved national health outcomes, a projection that hinges on sustained investment in prevention and value-based care. The United Arab Emirates has allocated $1.56B (AED 5.74B) for healthcare and community prevention services as part of its multi-year fiscal plan through 2026, reflecting a 10.4% increase from the 2024 budget.
What Comes Next
The Gulf Cooperation Council has set a benchmark that few middle-income regions can match, but sustaining 100% coverage will require addressing vaccine hesitancy, expanding adult immunization, and maintaining robust supply chains as new vaccines enter the market. Seasonal influenza campaigns, in particular, need renewed focus if the region hopes to replicate its childhood vaccination success across all age groups.
For residents and expatriates in the UAE and across the GCC, the achievement translates into tangible protection against preventable diseases, lower healthcare costs, and reduced absenteeism from school and work. As the UAE and broader GCC continue to invest in digital health, AI diagnostics, and global health initiatives, the region's role as both a high-performing health system and a major donor is likely to expand, offering a model—and financial support—for countries still striving to close their own immunization gaps.
